Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy

Recruiting now · Not applicable

Conditions studied: Colon Cancer, Oxaliplatin-induced Peripheral Neuropathy

In brief

The primary objective of this randomized clinical trial is to assess whether the use of surgical gloves during treatment can prevent the occurrence of oxaliplatin-induced peripheral neuropathy.

Key facts

Study ID

NCT07285356

Run by

AC Camargo Cancer Center

People needed

84

Starts

2025-10-06

Expected to finish

2026-09-18

Last updated by the study team

2025-12-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients aged 18 years or older who have provided written informed consent.
• Colon adenocarcinoma with high-risk stage III (pT4pN2) or stage IV.
• Oxaliplatin-based treatment in the context of localized or metastatic disease.
• Eastern Cooperative Oncology Group (ECOG) performance status of 0-1.

You may not qualify if…

• Pre-existing neuropathy.
• Uncontrolled diabetes.
• known glove allergies.
• Prior treatment with paclitaxel, docetaxel or oxaliplatin.

Where it is running

• A.C. Camargo Cancer Center — São Paulo, São Paulo, Brazil (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.